PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA)

Total Lobbying Spend

Filings

576

Firms Hired

Active Period

2000–2025

Spending by Year

Annual lobbying expenditures

Year	Total Spent	Filings	Firms
2025	—	23	7
2024	—	28	7
2023	—	30	9
2022	—	41	10
2021	—	42	11
2020	—	41	10
2019	—	37	9
2018	—	33	8
2017	—	24	6
2016	—	23	6
2015	—	22	6
2014	—	27	7
2013	—	26	7
2012	—	38	10
2011	—	37	9
2010	—	26	7
2009	—	33	9
2008	—	24	5
2007	—	4	2
2006	—	3	2
2005	—	6	3
2004	—	1	1
2003	—	2	1
2002	—	2	1
2001	—	2	1
2000	—	1	1

Most frequently reported lobbying issues

Issue Code	Description	Reports
Health Issues	—	368
Medicare/Medicaid	—	250
Trade (domestic/foreign)	—	119
Pharmacy	—	97
Copyright/Patent/Trademark	—	60
Medical/Disease Research/Clinical Labs	—	52
Taxation/Internal Revenue Code	—	50
Economics/Economic Development	—	49
Science/Technology	—	40
Budget/Appropriations	—	19
Clean Air and Water (quality)	—	8
Defense	—	4
Manufacturing	—	1
Consumer Issues/Safety/Products	—	1

Lobbying firms retained by this client

Firm Name	Total Paid	Filings
ADVANCED POLICY CONSULTING, LLC	—	40
ARNOLD & PORTER KAYE SCHOLER LLP	—	81
BREAUX LOTT LEADERSHIP GROUP	—	12
CAPITOL COUNSEL LLC	—	74
DERRICK WHITE	—	13
DESIMONE CONSULTING, LLC	—	57
FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)	—	7
FTI GOVERNMENT AFFAIRS	—	22
G. FOX CONSULTING	—	6
HOGAN LOVELLS US LLP	—	24
KLINK CAMPAIGNS, INC	—	13
MS. REBECCA HALKIAS	—	11
OGR	—	31
PRICEWATERHOUSECOOPERS	—	7
S-3 GROUP	—	14

Source: Senate Lobbying Disclosure Act (LDA) filings.